318 related articles for article (PubMed ID: 22795806)
61. Brain metastases from gynecological cancers: factors that affect overall survival.
Mahmoud-Ahmed AS; Kupelian PA; Reddy CA; Suh JH
Technol Cancer Res Treat; 2002 Aug; 1(4):305-10. PubMed ID: 12625790
[TBL] [Abstract][Full Text] [Related]
62. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.
Aoyama H; Shirato H; Onimaru R; Kagei K; Ikeda J; Ishii N; Sawamura Y; Miyasaka K
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):793-800. PubMed ID: 12788187
[TBL] [Abstract][Full Text] [Related]
63. Preoperative Versus Postoperative Radiosurgery of Brain Metastases: A Meta-Analysis.
Dharnipragada R; Dusenbery K; Ferreira C; Sharma M; Chen CC
World Neurosurg; 2024 Feb; 182():35-41. PubMed ID: 37918565
[TBL] [Abstract][Full Text] [Related]
64. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma.
Ikushima H; Tokuuye K; Sumi M; Kagami Y; Murayama S; Ikeda H; Tanaka M; Oyama H; Shibui S; Nomura K
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1389-93. PubMed ID: 11121638
[TBL] [Abstract][Full Text] [Related]
65. Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective review.
Khuntia D; Sajja R; Chidel MA; Lee SY; Rice TW; Adelstein DJ; Carlson TP; Saxton JP; Barnett GH; Suh JH
Technol Cancer Res Treat; 2003 Jun; 2(3):267-72. PubMed ID: 12779356
[TBL] [Abstract][Full Text] [Related]
66. Radiotherapy and radiosurgical management of brain metastases.
Flickinger JC
Curr Oncol Rep; 2001 Nov; 3(6):484-9. PubMed ID: 11595116
[TBL] [Abstract][Full Text] [Related]
67. Stereotactic radiation in primary brain tumors in children and adolescents.
Benk V; Clark BG; Souhami L; Algan O; Bahary J; Podgorsak EB; Freeman CR
Pediatr Neurosurg; 1999 Aug; 31(2):59-64. PubMed ID: 10592473
[TBL] [Abstract][Full Text] [Related]
68. The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases.
Patchell RA; Regine WF
Technol Cancer Res Treat; 2003 Apr; 2(2):111-5. PubMed ID: 12680791
[TBL] [Abstract][Full Text] [Related]
69. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases.
O'Neill BP; Iturria NJ; Link MJ; Pollock BE; Ballman KV; O'Fallon JR
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1169-76. PubMed ID: 12654423
[TBL] [Abstract][Full Text] [Related]
70. Brain metastases from unknown primary tumour: a prospective study.
Rudà R; Borgognone M; Benech F; Vasario E; Soffietti R
J Neurol; 2001 May; 248(5):394-8. PubMed ID: 11437161
[TBL] [Abstract][Full Text] [Related]
71. Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases.
Combs SE; Bilger A; Diehl C; Bretzinger E; Lorenz H; Oehlke O; Specht HM; Kirstein A; Grosu AL
Cancer Med; 2018 Jun; 7(6):2319-2327. PubMed ID: 29696815
[TBL] [Abstract][Full Text] [Related]
72. Radiosurgery for primary malignant brain tumors.
Alexander E; Loeffler JS
Semin Surg Oncol; 1998; 14(1):43-52. PubMed ID: 9407630
[TBL] [Abstract][Full Text] [Related]
73. Stereotactic radiosurgical treatment of brain metastases.
Adler JR; Cox RS; Kaplan I; Martin DP
J Neurosurg; 1992 Mar; 76(3):444-9. PubMed ID: 1738025
[TBL] [Abstract][Full Text] [Related]
74. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.
Hahnemann L; Krämer A; Fink C; Jungk C; Thomas M; Christopoulos P; Lischalk JW; Meis J; Hörner-Rieber J; Eichkorn T; Deng M; Lang K; Paul A; Meixner E; Weykamp F; Debus J; König L
Clin Transl Radiat Oncol; 2024 May; 46():100782. PubMed ID: 38694237
[TBL] [Abstract][Full Text] [Related]
75. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases.
Schöggl A; Kitz K; Reddy M; Wolfsberger S; Schneider B; Dieckmann K; Ungersböck K
Acta Neurochir (Wien); 2000; 142(6):621-6. PubMed ID: 10949435
[TBL] [Abstract][Full Text] [Related]
76. Clinical and volumetric predictors of local control after robotic stereotactic radiosurgery for cerebral metastases: active systemic disease may affect local control in the brain.
Blamek S; Stankiewicz M; Maciejewski B
Radiol Oncol; 2020 Nov; 55(1):82-87. PubMed ID: 33885238
[TBL] [Abstract][Full Text] [Related]
77. Oligodendroglioma. The Princess Margaret Hospital experience (1958-1984).
Nijjar TS; Simpson WJ; Gadalla T; McCartney M
Cancer; 1993 Jun; 71(12):4002-6. PubMed ID: 8508366
[TBL] [Abstract][Full Text] [Related]
78. [Stereotactic radiation therapy with a modified linear accelerator in patients with brain metastases].
Grosu AL; Feldmann HJ; Stärk S; Pinsker M; Nieder C; Kneschaurek P; Lumenta C; Molls M
Nervenarzt; 2001 Oct; 72(10):770-81. PubMed ID: 11688178
[TBL] [Abstract][Full Text] [Related]
79. Neuroinflammation After Stereotactic Radiosurgery-Induced Brain Tumor Disintegration Is Linked to Persistent Cognitive Decline in a Mouse Model of Metastatic Disease.
Chu C; Davis CM; Lan X; Hienz RD; Jablonska A; Thomas AM; Velarde E; Li S; Janowski M; Kai M; Walczak P
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):745-757. PubMed ID: 32470502
[TBL] [Abstract][Full Text] [Related]
80. Recurrent intracranial Masson's vegetant intravascular hemangioendothelioma. Case report and review of the literature.
Avellino AM; Grant GA; Harris AB; Wallace SK; Shaw CM
J Neurosurg; 1999 Aug; 91(2):308-12. PubMed ID: 10433320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
